Patients affected by Parkinson’s who are undergoing drug treatments are familiar (as are their physicians and families) with their clinical condition; in particular, they are aware of which motor symptoms persist despite their treatments.
The patients must assess Gondola AMPS outcomes according to the recovery of their movement capabilities.